36th week of 2020 patent applcation highlights part 18 |
Patent application number | Title | Published |
20200277306 | BIOLOGICALLY ACTIVE MOLECULES, CONJUGATES THEREOF, AND THERAPEUTIC USES | 2020-09-03 |
20200277307 | SYNTHESIS OF ETP DERIVATIVES | 2020-09-03 |
20200277308 | FUSED TRICYCLIC RING DERIVATIVES AS SRC HOMOLOGY-2 PHOSPHATASE INHIBITORS | 2020-09-03 |
20200277309 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | 2020-09-03 |
20200277310 | PODOPHYLLOTOXIN DERIVATIVES AND THEIR USE | 2020-09-03 |
20200277311 | PRECURSOR COMPOUND FOR PRODUCING PHOTOACTIVE LAYER OF THIN FILM SOLAR CELL AND PRODUCTION METHOD THEREOF | 2020-09-03 |
20200277312 | IMMUNOPROTEASOME INHIBITORS | 2020-09-03 |
20200277313 | PEROVSKITE, METHOD FOR PRODUCING SAME, AND SOLAR BATTERY COMPRISING SAME | 2020-09-03 |
20200277314 | ORIENTED PEROVSKITE CRYSTALS AND METHODS OF MAKING THE SAME | 2020-09-03 |
20200277315 | TITANIUM-CONTAINING FILM FORMING COMPOSITIONS FOR VAPOR DEPOSITION OF TITANIUM-CONTAINING FILMS | 2020-09-03 |
20200277316 | FLAME RETARDANT COMPOSITION, FLAME RETARDANT RESIN COMPOSITION CONTAINING SAID FLAME RETARDANT COMPOSITION, AND MOLDED BODY OF SAID FLAME RETARDANT RESIN COMPOSITION | 2020-09-03 |
20200277317 | CRYSTAL OF CYCLIC PHOSPHONIC ACID SODIUM SALT AND METHOD FOR MANUFACTURING SAME | 2020-09-03 |
20200277318 | CRYSTAL OF CYCLIC PHOSPHONIC ACID SODIUM SALT AND METHOD FOR MANUFACTURING SAME | 2020-09-03 |
20200277319 | COMPOUND, NANORIBBON, AND SEMICONDUCTOR DEVICE | 2020-09-03 |
20200277320 | SYNTHESIS OF CYCLIC ORGANIC COMPOUNDS AND METALLOCENES | 2020-09-03 |
20200277321 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALAOGS THEREOF | 2020-09-03 |
20200277322 | Steviol Glycosides, Their Compositions and Their Purification | 2020-09-03 |
20200277323 | MORPHIC FORMS OF 4-AMINO-7-(3,4-DIHYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-2-METHYL-- 7H-PYRROLO[2,3-d]PYRIMIDINE-5-CARBOXAMIDE AND USES THEREOF | 2020-09-03 |
20200277324 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATING DISEASES | 2020-09-03 |
20200277325 | NOVEL IRON COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | 2020-09-03 |
20200277326 | ARAMCHOL SALTS | 2020-09-03 |
20200277327 | METHOD FOR SYNTHESIZING PEPTIDE CONTAINING N-SUBSTITUTED AMINO ACID | 2020-09-03 |
20200277328 | METHOD FOR PREPARING LIXISENATIDE | 2020-09-03 |
20200277329 | METHODS FOR PREVENTING DISULFIDE BOND DEDUCTION IN CELL CULTURE HARVEST WITH SELENITE | 2020-09-03 |
20200277330 | METHODS FOR PURIFYING ANTIBODIES | 2020-09-03 |
20200277331 | NOVEL MODULATORS OF MELANOCORTIN RECEPTORS FOR THE TREATMENT OF DEPRESSION AND ANXIETY | 2020-09-03 |
20200277332 | PEPTIDE FOR INHIBITING ANGIOGENESIS AND USE THEREOF | 2020-09-03 |
20200277333 | SYNTHETIC SYSTEM FOR TUNABLE THRESHOLDING OF PROTEIN SIGNALS | 2020-09-03 |
20200277334 | ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES AND METHODS OF USE | 2020-09-03 |
20200277335 | VIRAL FUSION PROTEIN TREATMENT FOR CCR8 MEDIATED DISEASES | 2020-09-03 |
20200277336 | Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor | 2020-09-03 |
20200277337 | CHIMERIC RECEPTOR BINDING PROTEINS FOR USE IN BACTERIAL DELIVERY VEHICLES | 2020-09-03 |
20200277338 | RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING A CHIMERIC RSV/BPIV3 F PROTEIN AND USES THEREOF | 2020-09-03 |
20200277339 | FLAGELLIN COMPOSITIONS AND USES | 2020-09-03 |
20200277340 | NOVEL CHIMERIC INSECTICIDAL PROTEINS TOXIC OR INHIBITORY TO LEPIDOPTERAN PESTS | 2020-09-03 |
20200277341 | AN IMPROVED METHOD FOR HIGH LEVEL PRODUCTION OF CRM197 | 2020-09-03 |
20200277342 | NOVEL NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF | 2020-09-03 |
20200277343 | PREPARATION AND USE OF GINSENTIDES AND GINSENTIDE-LIKE PEPTIDES | 2020-09-03 |
20200277344 | PEA PROTEINS WITH IMPROVED FLAVOUR, PRODUCTION METHOD, AND INDUSTRIAL USES | 2020-09-03 |
20200277345 | Insecticidal Peptide Production, Peptide Expression in Plants and Combinations of Cysteine Rich Peptides | 2020-09-03 |
20200277346 | UBIQUITIN VARIANT MODULATORS OF HECT E3 LIGASES AND THEIR USES | 2020-09-03 |
20200277347 | POLYPEPTIDES FOR INHIBITING COMPLEMENT ACTIVATION | 2020-09-03 |
20200277348 | MULTI SPECIFIC MOLECULES | 2020-09-03 |
20200277349 | N-TERMINALLY TRUNCATED INTERLEUKIN-38 | 2020-09-03 |
20200277350 | PROTEINACEOUS HETERODIMER AND USE THEREOF | 2020-09-03 |
20200277351 | PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE | 2020-09-03 |
20200277352 | T CELL RECEPTORS RECOGNIZING MUTATED P53 | 2020-09-03 |
20200277353 | THERAPEUTIC AGENTS | 2020-09-03 |
20200277354 | MODULATORS OF NOTCH SIGNALING AND METHODS OF USE THEREOF | 2020-09-03 |
20200277355 | SELECTIVE TNFR1 ANTAGONIST PEPTIDE SN10 AND APPLICATION THEREOF IN INFLAMMATORY BOWEL DISEASE | 2020-09-03 |
20200277356 | FACTOR VIII PROTEINS HAVING ANCESTRAL SEQUENCES, EXPRESSION VECTORS, AND USES RELATED THERETO | 2020-09-03 |
20200277357 | NOVEL PEPTIDES THAT BIND TO TYPES OF MHC CLASS II AND THEIR USE ON DIAGNOSIS AND TREATMENT | 2020-09-03 |
20200277358 | ENGINEERED POLYPEPTIDES AND USES THEREOF | 2020-09-03 |
20200277359 | ANTIBODY-MEDIATED NEUTRALIZATION OF CHIKUNGUNYA VIRUS | 2020-09-03 |
20200277360 | C3B INACTIVATING POLYPEPTIDE | 2020-09-03 |
20200277361 | ANTI-TRANSTHYRETIN ANTIBODIES | 2020-09-03 |
20200277362 | Humanized Antibodies That Recognize Alpha-Synuclein | 2020-09-03 |
20200277363 | RECOMBINANT EGFL7, EGFL7 ANTIBODIES, AND USES THEREOF | 2020-09-03 |
20200277364 | TREATMENT OF OCULAR DISEASES WITH FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTI-VEGF Fab | 2020-09-03 |
20200277365 | ANTAGONIST ANTIBODIES AGAINST GDF-8 AND USES THEREFOR | 2020-09-03 |
20200277366 | MULTI-SPECIFIC ANTIBODY MOLECULES HAVING SPECIFICITY FOR TNF-ALPHA, IL-17A and IL-17F | 2020-09-03 |
20200277367 | ANTIBODY VARIANTS | 2020-09-03 |
20200277368 | Methods for Treating Psoriasis Using an Anti-IL-23 Antibody | 2020-09-03 |
20200277369 | METHOD OF TREATING HIDRADENTITIS SUPPURATIVA WITH IL-17 ANTAGONISTS | 2020-09-03 |
20200277370 | TREATMENT OF HIDRADENITIS SUPPURATIVA | 2020-09-03 |
20200277371 | Restricted Immunoglobulin Heavy Chain Mice | 2020-09-03 |
20200277372 | ANTI-LAG3 ANTIBODIES | 2020-09-03 |
20200277373 | ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF | 2020-09-03 |
20200277374 | ANTI-SIGLEC-7 ANTIBODIES AND METHODS OF USE THEREOF | 2020-09-03 |
20200277375 | BINDING AGENTS | 2020-09-03 |
20200277376 | Monoclonal Antibody Antagonizing and Inhibiting the Binding of Human PD-1 Antigen to Its Ligand, Preparation Method Therefor and Application Thereof | 2020-09-03 |
20200277377 | NOVEL MONOCLONAL ANTIBODIES TO CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4 (CTLA-4) | 2020-09-03 |
20200277378 | COMBINATION THERAPIES | 2020-09-03 |
20200277379 | PHARMACEUTICAL COMPOSITION COMBINING IMMUNOLOGIC AND CHEMOTHERAPEUTIC METHOD FOR THE TREATMENT OF CANCER | 2020-09-03 |
20200277380 | PD-L1-SPECIFIC ANTIBODIES AND METHODS OF USING THE SAME | 2020-09-03 |
20200277381 | ALPHA-V BETA-8 ANTIBODIES | 2020-09-03 |
20200277382 | BISPECIFIC ANTIBODY CONSTRUCTS AND METHODS OF USE | 2020-09-03 |
20200277383 | PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN | 2020-09-03 |
20200277384 | PROTEINS BINDING NKG2D, CD16, AND C-TYPE LECTIN-LIKE MOLECULE-1 (CLL-1) | 2020-09-03 |
20200277385 | Anti-CD303 Monoclonal Antibodies | 2020-09-03 |
20200277386 | AXL-SPECIFIC ANTIBODIES AND USES THEREOF | 2020-09-03 |
20200277387 | METHODS AND COMPOSITIONS FOR TREATING CANCER | 2020-09-03 |
20200277388 | TRISPECIFIC ANTAGONISTS | 2020-09-03 |
20200277389 | METHOD OF TREATMENT OF PHILADELPHIA CHROMOSOME POSITIVE LEUKEMIA | 2020-09-03 |
20200277390 | LIGANDS BINDING TO PRION PROTEIN FOR USE IN THE TREATMENT OF SYNUCLEINOPATHIES | 2020-09-03 |
20200277391 | ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEASES OR DISORDERS | 2020-09-03 |
20200277392 | BISPECIFIC ANTIGEN BINDING MOLECULE FOR A COSTIMULATORY TNF RECEPTOR | 2020-09-03 |
20200277393 | Human Anti-CD27 Antibodies | 2020-09-03 |
20200277394 | Antibodies That Bind CD39 and Uses Thereof | 2020-09-03 |
20200277395 | TETRAVALENT ANTI-PSGL-1 ANTIBODIES AND USES THEREOF | 2020-09-03 |
20200277396 | Treatment Method | 2020-09-03 |
20200277397 | ANTIBODIES | 2020-09-03 |
20200277398 | HUMANIZED ANTIBODIES AGAINST CEACAM1 | 2020-09-03 |
20200277399 | CYSTEINE ENGINEERED ANTIGEN-BINDING MOLECULES | 2020-09-03 |
20200277400 | CHIMERIC ANTIGEN RECEPTOR COMPOSITIONS | 2020-09-03 |
20200277401 | ANTI-COAGULATION FACTOR VIII ANTIBODY AND USE THEREOF | 2020-09-03 |
20200277402 | ANTIBODY SUBSTITUTING FOR FUNCTION OF BLOOD COAGULATION FACTOR VIII | 2020-09-03 |
20200277403 | PROXIMITY-BASED SORTASE-MEDIATED PROTEIN PURIFICATION AND LIGATION | 2020-09-03 |
20200277404 | COMPOSITIONS AND METHODS FOR REGULATION OF IMMUNE CELL ACTIVATION AND PROLIFERATION | 2020-09-03 |
20200277405 | COMPOSITION FOR ANTIBODY-DRUG CONJUGATE DIRECTED AGAINST TUMOR-CELL ASSOCIATED POLYSIALIC ACID | 2020-09-03 |